Hepcludex (bulevirtide) / Gilead, Hepatera 
Welcome,         Profile    Billing    Logout  

7 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hepcludex (bulevirtide) / Gilead
2019-001213-17: Efficacy and Safety of bulevirtide in patients with Chronic Hepatitis Delta

Not yet recruiting
3
150
Europe
bulevirtide, [bulevirtide], Lyophilisate for solution for injection
Gilead Sciences, Inc., Gilead Sciences, Inc, MYR GmbH, MYR GmbH, Gilead Sciences, Inc.
Chronic Hepatitis Delta, Chronic Hepatitis Delta, Diseases [C] - Virus Diseases [C02]
 
 
MYR 301, NCT03852719: Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

Completed
3
150
Europe, US, RoW
Bulevirtide, Myrcludex B, Hepcludex®
Gilead Sciences
Chronic Hepatitis Delta
11/20
08/24
2016-000395-13: Efficacy and Safety of Myrcludex B in Chronic Hepatitis D

Not yet recruiting
2
120
Europe
Myrcludex B, Powder for solution for injection, Film-coated tablet, Viread
Hepatera LLC, Hepatera LLC
Chronic Hepatitis D, Chronic Hepatitis D infection, Diseases [C] - Digestive System Diseases [C06]
 
 
2019-001485-15: This study will use an investigational product (bulevirtide) for the treatment of chronic hepatitis Delta to learn the therapeutic effect, and safety of the drug in humans.

Ongoing
2
175
Europe
Bulevirtide, Lyophilisate for solution for injection, Solution for injection, Pegasys
MYR GmbH, MYR GmbH
Chronic Hepatitis Delta, Chronic Hepatitis Delta, Diseases [C] - Virus Diseases [C02]
 
 
NCT05765344: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Recruiting
1
72
US
Bulevirtide, Hepcludex®, Myrcludex B
Gilead Sciences
Chronic Hepatitis D Infection
02/25
02/25
NCT05760300: A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

Recruiting
1
80
US
Bulevirtide (BLV), Hepcludex®, Myrcludex B
Gilead Sciences
Chronic Hepatitis D Infection
05/26
05/26
NCT05718700: Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

Recruiting
N/A
170
Europe
Bulevirtide, Hepcludex®
Gilead Sciences
Chronic Hepatitis D Infection
11/27
11/27

Download Options